ANI focuses on data insights to ramp up Cortrophin
24 Jun 2022 //
FIERCEPHARMA
U.S. sues Mallinckrodt, accuses drugmaker of defrauding Medicaid
04 Mar 2020 //
REUTERS
Data on Acthar® Gel Therapy in Symptomatic Sarcoidosis Published
26 Nov 2019 //
PR NEWSWIRE
Mallinckrodt receives SEC subpoena over Acthar gel lawsuit
07 Nov 2019 //
REUTER S
Mallinckrodt unloads its CDMO for $250M as potential liabilities mount
10 Sep 2019 //
FIERCE PHARMA
Mallinckrodt investors stream for the exits as opioid-tied bankruptcy talk mount
07 Sep 2019 //
FIERCEPHARMA
Mallinckrodt halts mid-stage Acthar trial citing pneumonia risk
19 Jul 2019 //
PHARMATIMES
Mallinckrodt to start ph 4 trial of H.P. Acthar gel for symptomatic sarcoidosis
09 Oct 2017 //
PHARMABIZ
Mallinckrodt Enrolls First Patient in Phase 2B Trial of H.P. ActharGel for ALS
14 Jun 2017 //
PR NEWSWIRE
Mallinckrodt explores sale of generic drugs business
01 Jun 2017 //
REUTERS
Jim Chanos slams Express Scripts and Mallinckrodt over high drug prices
19 May 2017 //
REUTERS
FDA Declares drug product removed for safety reasons
20 Jan 2017 //
LACHMAN CONSULTANTS
Shkreli Wasn’t the First to Hike Drug Prices—and He Won’t Be the Last
23 Dec 2015 //
BLOOMBERG
Mallinckrodt Drops on Mention by Valeant Foe Citron Research
11 Nov 2015 //
BLOOMBERG
Report Card: FDA Earns a Solid
25 Jan 2015 //
FDA LAW BLOG